Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 28;103(26):e38511.
doi: 10.1097/MD.0000000000038511.

Global research trends on systemic lupus erythematosus and thyroid cancers (1964-2023): A scientometric and visualized study

Hediyeh Alemi  1 , Naghmeh Khavandgar  1 , Iman Menbari Oskouie  2   3   4 , Heydar Ali Mardani-Fard  5 , Tahereh Rostami  6 , Azadeh AleTaha  7   8 , Niloofar Peykari  9 , Majid Alikhani  10 , Sayed Mahmoud Sajjadi-Jazi  8 , Amir Kasaeian  11   12   13 , Shirin Djalalinia  14 , Akbar Soltani  7   8
Affiliations

Global research trends on systemic lupus erythematosus and thyroid cancers (1964-2023): A scientometric and visualized study

Hediyeh Alemi et al. Medicine (Baltimore). .

Abstract

Over the past 3 decades numerous studies have reported an association between systemic lupus erythematosus (SLE) and thyroid cancers. However, there has been no scientometric analysis in this area of research. To perform a comprehensive scientometric analysis of the global literature published on the association between SLE and thyroid cancers. The data on publications within thyroid cancers in SLE patients were retrieved from the Scopus database using a defined search strategy from its first publication in 1964 to 2023. To conduct a collaboration mapping analysis among keywords, authors, journals, and territories, VOSviewer was utilized. Our final research resulted in 246 scientific publications with 8072 citations, which were published in 198 journals affiliated to 48 countries. A global upward trend has been observed in the last 20 years, with the highest number of publications in the year 2022 (n = 28; 11.4%). The United States led the global productivity ranking with 74 publications (30.1%), followed by China with 25 publications (10.2%). The most popular journals in this field were "Arthritis Research and Therapy" and "Frontiers in Endocrinology," while the most co-cited journal was "Autoimmunity Reviews." The top 3 most prolific authors were Bernatsky, S., Clarke, A.E., and Ramsey-Goldman, R with 9 publications each. This first scientometric study comprehensively offered an overview of the status of thyroid cancers in SLE patients, assessing scholarly productivity in this domain over a period of 50 years.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1.
Figure 1.
Annual trends of global publications and citations in SLE and thyroid cancers research field. Each bar in blue represents the number of every year’s publications. Each node in yellow indicates the number of every year’s citations.
Figure 2.
Figure 2.
The global distribution of SLE and thyroid cancers research productivity by document type.
Figure 3.
Figure 3.
The global distribution of SLE and thyroid cancers research productivity by country/territory.
Figure 4.
Figure 4.
Visualized citation density among the countries/territories.
Figure 5.
Figure 5.
The global distribution of SLE and thyroid cancers research productivity by institution.
Figure 6.
Figure 6.
The citation analysis network of journals.
Figure 7.
Figure 7.
Co-authorship map of authors.
Figure 8.
Figure 8.
Co-occurrence map of author keywords.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Choi MY, Flood K, Bernatsky S, et al. . A review on SLE and malignancy. Best Pract Res Clin Rheumatol. 2017;31:373–96. - PMC - PubMed
    1. Chen YJ, Chang Y-T, Wang C-B, et al. . Malignancy in systemic lupus erythematosus: a nationwide cohort study in Taiwan. Am J Med. 2010;123:1150.e1–6. - PubMed
    1. van Vollenhoven R, Askanase AD, Bomback AS, et al. . Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria. Lupus Sci Med. 2022;9:e000634. - PMC - PubMed
    1. Zhang M, Wang Y, Wang Y, et al. . Association between systemic lupus erythematosus and cancer morbidity and mortality: findings from cohort studies. Front Oncol. 2022;12:1–11. - PMC - PubMed
    1. Bae EH, Lim SY, Han K-D, et al. . Systemic lupus erythematosus is a risk factor for cancer: a nationwide population-based study in Korea. Lupus. 2019;28:317–23. - PubMed

Publication types

MeSH terms